Rakuten Investment Management Inc. bought a new position in Baxter International Inc. (NYSE:BAX – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 59,180 shares of the medical instruments supplier’s stock, valued at approximately $1,390,000.
A number of other institutional investors have also modified their holdings of BAX. Pzena Investment Management LLC acquired a new stake in Baxter International during the second quarter valued at $1,392,098,000. Tocqueville Asset Management L.P. purchased a new position in Baxter International in the second quarter valued at about $30,604,000. BlackRock Inc. purchased a new position in Baxter International in the second quarter valued at about $1,744,874,000. AMG National Trust Bank acquired a new position in Baxter International in the 2nd quarter worth about $2,522,000. Finally, Edmond DE Rothschild Holding S.A. acquired a new position in Baxter International in the 2nd quarter worth about $51,958,000. Institutional investors and hedge funds own 90.19% of the company’s stock.
Baxter International Stock Up 0.3%
Shares of BAX stock opened at $25.73 on Friday. The stock’s 50 day simple moving average is $24.50 and its 200 day simple moving average is $21.51. Baxter International Inc. has a twelve month low of $15.73 and a twelve month high of $30.00. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.19 and a current ratio of 1.79. The company has a market capitalization of $13.31 billion, a price-to-earnings ratio of -18.25, a PEG ratio of 3.80 and a beta of 0.68.
Baxter International Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, November 27th will be issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, November 27th. Baxter International’s dividend payout ratio is currently -2.84%.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on BAX shares. JPMorgan Chase & Co. cut their price target on Baxter International from $26.00 to $25.00 and set a “neutral” rating for the company in a research note on Friday, October 30th. Jefferies Financial Group reissued a “hold” rating and issued a $25.00 price target on shares of Baxter International in a research note on Thursday, October 29th. Zacks Research upgraded Baxter International from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 11th. TD Cowen raised their price objective on shares of Baxter International from $20.00 to $24.00 and gave the company a “hold” rating in a research report on Monday, July 27th. Finally, UBS Group lifted their target price on shares of Baxter International from $19.00 to $25.00 and gave the company a “hold” rating in a research note on Tuesday, July 28th. One investment analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Reduce” and an average target price of $23.00.
Get Our Latest Stock Report on BAX
About Baxter International
Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care.
The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.
Founded in 1931, Baxter began by producing intravenous solutions.
Read More
- Five stocks we like better than Baxter International
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.
